21P Stock Overview
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Aurora Cannabis Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$5.86 |
| 52 Week High | CA$9.03 |
| 52 Week Low | CA$3.62 |
| Beta | 2.93 |
| 1 Month Change | 36.22% |
| 3 Month Change | n/a |
| 1 Year Change | 9.25% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -91.51% |
Recent News & Updates
Recent updates
Shareholder Returns
| 21P | BG Pharmaceuticals | BG Market | |
|---|---|---|---|
| 7D | -13.4% | 2.5% | 0.6% |
| 1Y | 9.2% | 9.7% | 17.1% |
Return vs Industry: 21P matched the BG Pharmaceuticals industry which returned 10% over the past year.
Return vs Market: 21P underperformed the BG Market which returned 17.2% over the past year.
Price Volatility
| 21P volatility | |
|---|---|
| 21P Average Weekly Movement | 20.5% |
| Pharmaceuticals Industry Average Movement | 5.0% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in BG Market | 8.2% |
| 10% least volatile stocks in BG Market | 2.4% |
Stable Share Price: 21P's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 21P's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 1,130 | Miguel Martin | www.auroramj.com |
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Aurora Cannabis Inc. Fundamentals Summary
| 21P fundamental statistics | |
|---|---|
| Market cap | €469.56m |
| Earnings (TTM) | €279.54m |
| Revenue (TTM) | €187.77m |
1.7x
P/E Ratio2.5x
P/S RatioIs 21P overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 21P income statement (TTM) | |
|---|---|
| Revenue | CA$275.88m |
| Cost of Revenue | CA$190.60m |
| Gross Profit | CA$85.29m |
| Other Expenses | -CA$325.43m |
| Earnings | CA$410.72m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.53 |
| Gross Margin | 30.91% |
| Net Profit Margin | 148.87% |
| Debt/Equity Ratio | 9.8% |
How did 21P perform over the long term?
See historical performance and comparison